Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC - Author's reply. Wu YL. Lancet Oncol 2022;23:e159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu YL. Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC - Author's reply. Lancet Oncol 2022;23:e159.
PMID: 35358459